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Early Allograft Dysfunction (EAD), the clinical manifestation of Ischemia 
Reperfusion Injury (IRI), is characterized by a poor graft function immediately after 
Liver Transplantation (LTx). Because of concerns regarding EAD after LTx, we 
assessed incidence, risk factors and consequences  of EAD on outcomes post-LTx 
in our center. 
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RESULTS 
Retrospective review:  
• January 2000 to December 2010  
• 552 LTx were performed with complete follow-up  (12 to 132 months). 
(end of follow-up 31/12/2010)  
• Exclusion criteria:  
- < 18 yo 
- Combined transplantations  
- Split and living donation  
 
 
Definition of EAD post-LTx (Olthoff) (1):  
• Bilirubine > 10 mg/dL on day 7 and/or  
• International normalized ratio (INR) > 1.6 on day 7 and/or  
• AST or ALT > 2000 UI/L within the first 7 days after LTx. 
LTx recipients who don’t full fill EAD criteria are defined as immediate functioning  
(IF) LTx. Primary non function (PNF) is defined as the need for retransplantation 






Procurement team: locally procured vs. 
imported 0,51 (0,31 – 0,84) <0,01 
Preservation solution type: UW vs. HTK 0,53 (0,31 – 0,91) 0,02 
Cold ischemic time (hrs) 1,17 (1,04 – 1,32) 0,01 
Lab MELD score 1,06 (1,01 – 1,12) 0,02 








ICU stay (days) 3 (2 – 6) 6 (3 – 19) <0,01 
Hospital stay (days) 18 (14 – 27) 25 (18 – 44) <0,01 
Reference: (1) Olthofff KM, Kulik L, Kaminski M et al. Liver Transpl. 2010; 16: 943-949. Validation of a current definition of early allogrfat dysfunction in liver transplant recipients and analysis of risk factors. 
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In our series, EAD incidence is 27%  
 
Independent risk factors of EAD post-LTx in our series are: 
• Imported livers 
• Cold ischemic time 
• Length of surgery 
• HTK 
• Lab MELD score 
 
Surprisingly, Extended Criteria Donor (ECD) & Donation after 
Ciruculatory Death (DCD) were not associated with EAD post-LTx. 
 
EAD is associated with a significant:  
• Longer ICU and hospital stays   
• Higher risk of patient death 
EAD is not an innocent temporary phase. This study highlights 
the importance of immediate function post LTx and its impact 
on LTx recipient survival.  
 
Strategies to reduce EAD are therefore urgently needed. They 
should primarily focus on: improving procurement strategies, 
re-questioning HTK preservation, reducing cold ischemia time. 
In addition, optimizing preservation techniques (e.g. machine 
perfusion) and pharmacological modulation of IRI in recipient 













Note that death of the receptor is a competing risk for retransplantation. As such, this 
Kaplan-Meier curve represents the expected percentage of patients with a 
retransplantion in a hypothetical population of patients who are not at risk of dying. 
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